Literature DB >> 24295237

A psychometric evaluation of the panic disorder severity scale for children and adolescents.

R Meredith Elkins1, Donna B Pincus1, Jonathan S Comer2.   

Abstract

The Panic Disorder Severity Scale (PDSS; Shear et al., 1997) is a well-validated measure that assesses symptoms of panic disorder with or without agoraphobia (PDA) in adults. The Panic Disorder Severity Scale for Children (PDSS-C) is an adaptation of the PDSS for youth ages 11-17. The current study evaluated the psychometric properties of the PDSS-C. Participants included 60 adolescents from a randomized controlled trial investigating the efficacy of an intensive cognitive behavioral treatment (CBT) for adolescent PDA. Convergent and discriminant validity of PDSS-C scores were evaluated via observed associations between the PDSS-C and the Childhood Anxiety Sensitivity Index (CASI; Silverman, Fleisig, Rabian, & Peterson, 1991), Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, Stallings, & Conners, 1997), and Children's Depression Inventory (CDI; Kovacs, 2003). Baseline and posttreatment data afforded the opportunity to evaluate the measure's sensitivity to treatment-related change. PDSS-C scores demonstrated acceptable internal consistency (α = .82) and adequate 1-day test-retest reliability (r = .79). Convergent and discriminant validity of the PDSS-C scores were supported through significant associations with the CASI and the MASC, and nonsignificant associations with the CDI, respectively. Linear regression analysis demonstrated sensitivity to treatment-related changes-that is, greater PDSS-C change scores were significantly associated with assignment to CBT vs. waitlist condition. Clinical utility was further established through significant associations between PDSS-C change scores and MASC and CASI change scores, and through nonsignificant associations with CDI change scores. Results support the use of PDSS-C scores as reliable, valid, and clinically useful for the assessment of youth panic disorder in research and clinical settings.

Entities:  

Mesh:

Year:  2013        PMID: 24295237      PMCID: PMC4049332          DOI: 10.1037/a0035283

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  48 in total

Review 1.  School refusal in children and adolescents: a review of the past 10 years.

Authors:  N J King; G A Bernstein
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

2.  A longitudinal investigation of anxiety sensitivity in adolescence.

Authors:  Carl F Weems; Chris Hayward; Joel Killen; C Barr Taylor
Journal:  J Abnorm Psychol       Date:  2002-08

3.  Reliability and validity of the Panic Disorder Severity Scale: replication and extension.

Authors:  M K Shear; P Rucci; J Williams; E Frank; V Grochocinski; J Vander Bilt; P Houck; T Wang
Journal:  J Psychiatr Res       Date:  2001 Sep-Oct       Impact factor: 4.791

4.  Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

Authors:  W K Silverman; L M Saavedra; A A Pina
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-08       Impact factor: 8.829

5.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Authors:  D H Barlow; J M Gorman; M K Shear; S W Woods
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

6.  The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders.

Authors:  D S Pine; P Cohen; D Gurley; J Brook; Y Ma
Journal:  Arch Gen Psychiatry       Date:  1998-01

7.  Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

Authors:  Jeffrey J Wood; John C Piacentini; R Lindsey Bergman; James McCracken; Velma Barrios
Journal:  J Clin Child Adolesc Psychol       Date:  2002-09

8.  Recurrent pain, emotional distress, and health service use in childhood.

Authors:  John V Campo; Diane M Comer; Linda Jansen-Mcwilliams; William Gardner; Kelly J Kelleher
Journal:  J Pediatr       Date:  2002-07       Impact factor: 4.406

9.  Reliability of the self-report version of the panic disorder severity scale.

Authors:  Patricia R Houck; David A Spiegel; M Katherine Shear; Paola Rucci
Journal:  Depress Anxiety       Date:  2002       Impact factor: 6.505

10.  Multiple informant agreement and the anxiety disorders interview schedule for parents and children.

Authors:  Amie E Grills; Thomas H Ollendick
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-01       Impact factor: 8.829

View more
  7 in total

1.  Free, brief, and validated: Standardized instruments for low-resource mental health settings.

Authors:  Rinad S Beidas; Rebecca E Stewart; Lucia Walsh; Steven Lucas; Margaret Mary Downey; Kamilah Jackson; Tara Fernandez; David S Mandell
Journal:  Cogn Behav Pract       Date:  2015-02-01

2.  Moderators of intensive CBT for adolescent panic disorder: the of fear and avoidance.

Authors:  R Meredith Elkins; Kaitlin P Gallo; Donna B Pincus; Jonathan S Comer
Journal:  Child Adolesc Ment Health       Date:  2015-09-08       Impact factor: 2.175

3.  Predictors of Treatment Satisfaction Among Adolescents Following an Intensive Cognitive-Behavioral Intervention for Panic Disorder.

Authors:  Maya Nauphal; Ovsanna T Leyfer; Erin F Ward-Ciesielski; Donna B Pincus
Journal:  Child Psychiatry Hum Dev       Date:  2020-09-03

4.  Adolescents' lived experience of panic disorder: an interpretative phenomenological analysis.

Authors:  Holly J Baker; Amelia Hollywood; Polly Waite
Journal:  BMC Psychol       Date:  2022-06-06

5.  N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.

Authors:  Ovsanna Leyfer; Aubrey Carpenter; Donna Pincus
Journal:  Child Psychiatry Hum Dev       Date:  2019-04

6.  Study Protocol for a Randomized Double Blind, Placebo Controlled Trial Exploring the Effectiveness of a Micronutrient Formula in Improving Symptoms of Anxiety and Depression.

Authors:  Meredith Blampied; Caroline Bell; Claire Gilbert; Joseph Boden; Rebecca Nicholls; Julia J Rucklidge
Journal:  Medicines (Basel)       Date:  2018-06-14

7.  Protocol for a randomised controlled feasibility study examining the efficacy of brief cognitive therapy for the Treatment of Anxiety Disorders in Adolescents (TAD-A).

Authors:  Lucy Taylor; Polly Waite; Brynjar Halldorsson; Ray Percy; Mara Violato; Cathy Creswell
Journal:  Trials       Date:  2019-04-25       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.